SOHM (SHMN) PEG Ratio: N/A (As of Jun. 27, 2026)


What is SOHM PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, SOHM's PE Ratio without NRI is . SOHM's 5-Year EBITDA growth rate is 0.00%. Therefore, SOHM's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for SOHM's PEG Ratio or its related term are showing as below:



SHMN's PEG Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.71
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


SOHM  (OTCPK:SHMN) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


SOHM PEG Ratio Related Terms


SOHM PEG Ratio Historical Data

* Premium members only.

The historical data trend for SOHM's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SOHM PEG Ratio Chart

SOHM Annual Data
Trend
PEG Ratio

SOHM Quarterly Data
PEG Ratio

SHMN vs NUVPF, ADMD, RSPI: PEG Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, SOHM's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SOHM PEG Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SOHM's PEG Ratio distribution charts can be found below:

* The bar in red indicates where SOHM's PEG Ratio falls into.



SOHM PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

SOHM's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


SOHM Business Description

Address 4195 Chino Hills Parkway, Suite 675, Chino Hills, CA, USA, 91709
SOHM Inc is a pharmaceutical, cosmeceutical, nutraceutical and biotech manufacturer that produces and markets generic drugs and products for various treatment categories. The products of the company include OTC and RX: Generic CDMO Services, and ABBIE Systems. The organization markets and sells its generic drugs globally but focuses on emerging markets in Africa, Latin America, Southeast Asia, and others.